0001127602-24-007628.txt : 20240229 0001127602-24-007628.hdr.sgml : 20240229 20240229163230 ACCESSION NUMBER: 0001127602-24-007628 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240228 FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WADE JEFFREY L CENTRAL INDEX KEY: 0001225767 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30111 FILM NUMBER: 24704308 MAIL ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001062822 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 760474169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2445 TECHNOLOGY FOREST BLVD. STREET 2: SUITE 1100 CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2818633000 MAIL ADDRESS: STREET 1: 2445 TECHNOLOGY FOREST BLVD. STREET 2: SUITE 1100 CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE DATE OF NAME CHANGE: 20070426 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON GENETICS INC/TX DATE OF NAME CHANGE: 20000126 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-02-28 0001062822 LEXICON PHARMACEUTICALS, INC. LXRX 0001225767 WADE JEFFREY L 2445 TECHNOLOGY FOREST BLVD. 11TH FLOOR THE WOODLANDS TX 77381 1 President and CFO 0 Common Stock 2024-02-28 4 M 0 11177 A 275518 D Common Stock 2024-02-28 4 M 0 37274 A 312792 D Common Stock 2024-02-28 4 M 0 49113 A 361905 D Common Stock 2024-02-28 4 F 0 37691 2.62 D 324214 D Restricted Stock Units 2024-02-28 4 M 0 11177 D Common Stock 11177 0 D Restricted Stock Units 2024-02-28 4 M 0 37274 D Common Stock 37274 37273 D Restricted Stock Units 2024-02-28 4 M 0 49113 D Common Stock 49113 98227 D Each restricted stock unit represents a contingent right to receive one share of common stock. Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. /s/ Jeffrey L. Wade 2024-02-29